www.ustoo.org    |   Donate  |    View in Browser

Made possible by a charitable contribution from Bayer
Navigation Tip: Click on blue text that’s italicized, underlined and in bold for link to more information.

Greetings!

We hope you are doing well and staying cool as we begin to wind down from the summer season!

We’re pleased to provide you with some of the latest Prostate Cancer News You Can Use . In addition to the following updates and information that may be of interest to you, the titles of prostate cancer news articles are listed below along with a link to the Us TOO web page that provides access to the full text for each article.

Recently, Congress expanded the geographic limits for exposure to Agent Orange . Veterans who served on vessels within 12 nautical miles seaward from the demarcation line of waters of Vietnam and Cambodia as defined in Public Law 116-23 (Blue Water Navy) between January 9, 1962, and May 7, 1975, are presumed to have been exposed to herbicides such as Agent Orange and may be entitled to service connection for conditions related to that exposure.  Read more in the press release and find additional information including a list of conditions in the fact sheet .

BRCA Blue  is a program to help educate patients and caregivers about the  connection between BRCA gene mutations and prostate cancer.  While some people may have heard about BRCA genes and their relationship to breast and ovarian cancers, research has shown a connection to other cancers as well – including prostate cancer. Men who have a BRCA mutation are at a higher risk for developing prostate cancer than men without a BRCA mutation. To learn more about this important gene, visit BRCAblue.com .

Inspire Patient Pulse recently featured an article about the recognition of prostate cancer being a “couple’s disease” relative to the potential impact that treatment side effects can have on the sexual health of a man, intimacy with his partner, and overall quality of life. 

The Prostate Cancer Foundation has recently updated their Patient Guide to reflect the very latest research and discoveries for prostate cancer patients. Download the updated digital copy.

We’re looking forward to hosting the  15 th Annual SEA Blue Chicago Prostate Cancer Walk & Run   on Sunday, September 15, in Lincoln Park! SEA is an acronym for  S upport,  E ducate and  A dvocate; and  blue is to prostate cancer  as pink is to breast cancer. Register to join us at the event, if possible; or register as a virtual mover at no charge if you will not attend in person and want to help fundraise. For a glimpse into what makes this event so special for so many people,  check out the video .

If you are in the Seattle area on September 15th, please join us for a walk around beautiful Greenlake Park!  CLICK HERE t o attend or donate to the
SEAttle Satellite SEA Blue Prostate Cancer Walk.
 
If you want to set up your own Satellite SEA Blue event , register for free as a Virtual Mover to set up your event/team at www.seablueprostatewalk.org .

Join PCRI on September 6 - 8 for the 2019 PCRI Prostate Cancer Patient Conference and get face to face with prostate cancer experts in every field. Hosted at the Los Angeles Airport Marriott, the PCRI conference is a full-featured educational experience for prostate cancer patients and caregivers. Each day consists of straightforward presentations, extended Q+A sessions, individualized small-group sessions, and a variety of fun and enriching activities to facilitate camaraderie. You can expect to gain a comprehensive knowledge of your disease and become empowered to make the best decisions for your life. Choose your strategy and win the fight!  Watch the new promotional video!   Register using the code "UsTOO" for a discounted patient registration rate of $30.00.

Malecare is hosting a Prostate Cancer Patient Conference on October 5. Presentations throughout the day will feature 12 physicians, including six from Memorial Sloan Kettering, breakfast, lunch, snacks and drinks. Discounted rooms are provided at the Intercontinental Barclay hotel in Manhattan.  Register with the promotion code "UsTOO" for a 50% discount. CLICK HERE for event information and registration.

Check out  educational video from the 2019 CPCC/UCSF Patient Conference on Prostate Cancer . The event took place on June 8 and was presented by the California Prostate Cancer Coalition and UCSF Helen Diller Family Comprehensive Cancer Center.

Us TOO recently had the opportunity to provide perspective on the approach to developing patient surveys on the Change Together blog. Read the post.

NEWS YOU CAN USE ARTICLES:

Please note that the content below lists only the title of the article rather than a direct link to the content. For access to the full article  CLICK HERE .

  • FDA approves Bayer's Nubeqa® (darolutamide), a new treatment for men with non-metastatic castration-resistant prostate cancer

  • AstraZeneca and MSD report positive data from trial of Lynparza

  • EMA to review XTANDI (enzalutamide) for mHSPC patients

  • Studies from University of British Columbia Yield New Data on Prostate Cancer (Factors associated with exercise preferences, barriers and facilitators of prostate cancer survivors)

  • Hormone therapy for prostate cancer may raise risk of Alzheimer’s, Dementia

  • Studies from Toyo University in the Area of Prostate Cancer Described (Combination Effect of Bowman-birk Inhibitor and Alpha-tocopheryl Succinate On Prostate Cancer Stem-like Cells)

  • New Prostate Cancer Study Results from Brigham and Women’s Hospital Described (Quality of Care In the Treatment of Localized Intermediate and High Risk Prostate Cancer At Minority Serving Hospitals)

  • New Prostate Cancer Study Findings Have Been Reported by Researchers at National Cancer Institute (When To Biopsy the Seminal Vesicles: a Validated Multiparametric Magnetic Resonance Imaging and Target Driven Model To Detect Seminal Vesicle ...)

  • New Findings on Prostate Cancer from University of Alberta Summarized (Exercise duRing Active Surveillance for prostatE cancer-the ERASE trial: a study protocol of a phase II randomised controlled trial)

  • Findings from H. Lee Moffitt Cancer Center and Research Institute Yields New Data on Prostate Cancer (African American Specific Gene Panel Predictive of Poor Prostate Cancer Outcome)

  • Recent Studies from H. Lee Moffitt Cancer Center and Research Institute Add New Data to Prostate Cancer (Multidrug Cancer Therapy In Metastatic Castrate-resistant Prostate Cancer: an Evolution-based Strategy)

  • An African American fraternity is getting the word out about prostate cancer and clinical trials


September – Prostate Cancer Awareness Month – is just around the corner. Watch for the September issue of the Us TOO  Hot SHEET  newsletter next week; and let us know how we can help provide you with educational resources, support services and personal connections to others in the prostate cancer community.


All the best,




Chuck Strand, Chief Executive Officer
James Hutson, Development Director
Jackie Konieczka, Office Manager
Terri Likowski, Program Director - Support Group Services
Tim Mix, Communications Manager